Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Calcipotriol Gel Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia
NCT07658508Phase 3Active, not recruiting
- Sponsor
- Alexandria University
- Start
- Jul 2025
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
A Phase 3 trial of AKP01 in oral leukoplakia, sponsored by Alexandria University. Started Jul 2025; status: active, not recruiting.
02
Drugs
AKP01
03
Conditions
oral leukoplakia
Beyond the preview
Go deeper on NCT07658508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07658508.